col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


46 Ergebisse       Seite 1

 [1] 
S. Karger AG: Acta Haematologica
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Mrz―27 Impact of COVID-19 on Patients with Beta-Thalassemia <i>Major</i>: An Observational Study Nadia Vacca, Cristian Locci, Fabiola Serra, Elena Chicconi, Mariangela V. Puci, Giovanni Sotgiu, et al. (+2)
2 [GO] 2024―Mrz―13 Persistent COVID-19: A Case Report of an Immunocompromised Patient and a Literature Review Sirine Bekkaoui, Geoffroy Venton, Fannie Bretelle, Victoria Garrido, Victor Chabbert, Stéphane Gayet, et al. (+6)
3 [GO] 2024―Mrz―12 Efficacy of preexposure prophylaxis with monoclonal-antibody tixagevimab-cilgavimab against emerging SARS-CoV-2 resistant variants in patients with chronic lymphocytic leukemia Ohad Benjamini, Tamar Tadmor, Abraham Avigdor, Rotem Gershon, Limor Kliker, Florin Fares, et al. (+7)
4 [GO] 2024―Feb―16 Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies Richard Blennerhassett, Nada Hamad, Lisa Grech, Alastair Kwok, Tammie Choi, Cecily Forsyth, et al. (+8)
5 [GO] 2023―Okt―11 COVID-19 in Patients with Chronic Lymphocytic Leukemia - What Have We Learned? Reut Harel, Gilad Itchaki
6 [GO] 2023―Aug―08 Clinical outcomes of COVID-19 in Mycosis Fungoides and Sezary Syndrome Ilana Levy Yurkovski, Lior Rokach, Guy Melamed, Hillel Alapi, Sivan Gazit, Tal Patalon, Tamar Tadmor
7 [GO] 2023―Jun―16 Adverse effects of COVID-19 vaccination in patients with Transfusion Dependent Thalassemia (TDT): an observational study from a tertiary care centre in Punjab, India. Shruti Kakkar, Evani Jain, Anirudh Jain, Priyanka Dewan
8 [GO] 2023―Feb―20 Acquired von Willebrand syndrome following a SARS-CoV2 infection Michael Iarossi, Cédric Hermans
9 [GO] 2022―Dez―20 Antithrombin Activity is Associated with Persistent Thromboinflammation and Mortality in Patients with Severe COVID-19 Illness Amber Chen-Goodspeed, GOUTHAM Dronavalli, Xu Zhang, Jeanette Podbielski, Bela Patel, Katalin Modis, et al. (+3)
10 [GO] 2022―Dez―20 The effectiveness of the intermediate and therapeutic doses of enoxaparin in COVID-19 patients: A comparative study of factor Xa inhibition Mansour Masjedi, Sina Azadikhah, Farid Zand, Naeimehossadat Asmarian, Golnar Sabetian, Mina Ostovan, Vida Naderi-boldaji
11 [GO] 2022―Nov―30 A Co-Management Model For Myeloid Malignancies that Evolved During the COVID-19 Pandemic Niyati Goradia, Aditi Shastri, Amit Verma, Eric Feldman, Dennis Cooper, Marina Konopleva, et al. (+10)
12 [GO] 2022―Okt―21 Association between thrombin generation and clinical characteristics in COVID-19 patients Omri Cohen, Nitsan Landau, Einat Avishai, Tami Brutman-Barazani, Ivan Budnik, Tami Livnat, et al. (+9)
13 [GO] 2022―Sep―12 A case of hemophagocytic lymphohistiocytosis following second dose of COVID-19 vaccination Hee Won Park, Gi June Min, Tong Yoon Kim, Seok-Goo Cho
14 [GO] 2022―Apr―21 A systematic review assessing the under-representation of cancer patients in COVID-19 trials Shira Buchrits, Danielle Fredman, Kim Ben Tikva Kagan, Anat Gafter-Gvili
15 [GO] 2022―Mrz―21 Hematological Aspects of COVID-19 Dafna Yahav
16 [GO] 2022―Mrz―02 COVID-19 in Patients with Hematological Malignancies (HM) - Clinical Manifestations, Persistence and Immune Response Ivan Gur, Amir Giladi, Yonathan Nachum Isenberg, Ami Neuberger, Anat Stern
17 [GO] 2022―Feb―25 Vaccination for SARS-CoV-2 in Hematological Patients Niccolo Riccardi, Marco Falcone, Dafna Yahav
18 [GO] 2022―Feb―08 COVID-19 Coagulopathy: From Pathogenesis to Treatment Teba Alnima, Mark M.G. Mulder, Bas C.T. van Bussel, Hugo ten Cate
19 [GO] 2022―Feb―08 COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments José Carlos Martínez, R Alejandro Sica, Keith Stockerl-Goldstein, Samuel M. Rubinstein
20 [GO] 2022―Feb―08 SARS-CoV-2 Infection and Blood Safety Baoren He, Yaoqiang Shi, Bin Li, Xiaoqiong Duan, Qinghua Wang
21 [GO] 2022―Feb―08 Challenges and Management of Long COVID in Individuals with Hematological Illnesses Dana Yelin, Ili Margalit
22 [GO] 2022―Jan―31 Imaging of Hematological Patients in the Era of COVID-19 Yael Eshet, Abraham Avigdor, Meirav Kedmi, Noam Tau
23 [GO] 2022―Jan―31 Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients Dmitri Guz, Anat Gafter-Gvili, Nirit Lev, Gal Sahaf Levin, Shaul Lev
24 [GO] 2021―Nov―26 Management of Persistent SARS-CoV-2 Infection in Patients with Follicular Lymphoma Pilar Martínez-Barranco, Maria García-Roa, Roberto Trelles-Martínez, Karmele Arribalzaga, María Velasco, Carlos Guijarro, et al. (+9)
25 [GO] 2021―Okt―19 Increased Incidence of Thrombosis in a Cohort of Cancer Patients with COVID-19 Phaedon Dimitrios Zavras, Vikas Mehta, Sanjay Goel, Kith Pradhan, Henny H. Billett
26 [GO] 2021―Sep―17 COVID-19 Infection in Sickle Cell Patients in a Developing Country: A Case Series Ana Cristina Silva-Pinto, Letícia Santos-Oliveira, Flávia Leite Souza Santos, Simone Kashima Haddad, Gil Cunha De Santis, Rodrigo do Tocantins Calado
27 [GO] 2021―Jun―10 Ruxolitinib for Severe COVID-19-Related Hyperinflammation in Nonresponders to Steroids Mauricio Sarmiento, Patricio Rojas, Joaquin Jerez, Pablo Bertín, James Campbell, Maria J. García, et al. (+3)
28 [GO] 2021―Apr―23 An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review Maya Kornowski Cohen, Liron Sheena, Yair Shafir, Vered Yahalom, Anat Gafter-Gvili, Galia Spectre
29 [GO] 2021―Apr―20 Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy Mariantonietta Di Stefano, Michelina Sarno, Giuseppina Faleo, Ahmed Mohamed Farhan Mohamed, Maria Rosaria Lipsi, Rosella De Nittis, et al. (+10)
30 [GO] 2021―Apr―19 Systematic Review of Microthrombi in COVID-19 Autopsies Rafael Parra-Medina, Sabrina Herrera, Jaime Mejia
31 [GO] 2021―Apr―15 From the Editor’s Desk: Publishing in Times of a Pandemic Pia Raanani
32 [GO] 2021―Mrz―29 How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic? Haowen Xiao, Yi Luo, Jimin Shi, Aiyun Jin, Mohamad Mohty, Arnon Nagler, et al. (+2)
33 [GO] 2021―Feb―27 Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic Petra Langerbeins, Barbara Eichhorst
34 [GO] 2020―Nov―06 Is G-CSF Dangerous in COVID-19: Why Not Use GM-CSF? Hillard M. Lazarus, Robert Peter Gale
35 [GO] 2020―Okt―08 A Haematologist’s Guide to Coronavirus Disease 2019: Encyclopaedia or Doorstop? Robert Peter Gale
36 [GO] 2020―Sep―25 Management of COVID-19 Coagulopathy in a Patient with Severe Haemophilia A João Pinto Pereira, Philippe Hantson, Ludovic Gerard, Xavier Wittebole, Pierre-François Laterre, Catherine Lambert, Cédric Hermans
37 [GO] 2020―Sep―15 COVID-19 in Patients with Hematologic Disorders Undergoing Therapy: Perspective of a Large Referral Hematology Center in Rome Corrado Girmenia, Giuseppe Gentile, Alessandra Micozzi, Luigi Petrucci, Francesco Malaspina, Alessio Di Prima, et al. (+8)
38 [GO] 2020―Aug―25 Red Blood Cell Distribution Is a Significant Predictor of Severe Illness in Coronavirus Disease 2019 Giuseppe Lippi, Brandon M. Henry, Fabian Sanchis-Gomar
39 [GO] 2020―Aug―20 Ruxolitinib in COVID-19 Hyperinflammation and Haematologic Malignancies Felicitas La Rosée, Paul La Rosée
40 [GO] 2020―Aug―13 G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19? Hillard M. Lazarus, Robert Peter Gale
41 [GO] 2020―Jul―29 JAK/STAT Pathway Inhibition May Be a Promising Therapy for COVID-19-Related Hyperinflammation in Hematologic Patients Patricio Rojas, Mauricio Sarmiento
42 [GO] 2020―Jul―28 Coronavirus Disease 2019 (COVID-19): A Haematologist’s Perspective Carmen Ka Man Cheung, Man Fai Law, Grace Chung Yan Lui, Sunny Hei Wong, Raymond Siu Ming Wong
43 [GO] 2020―Mai―12 Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far? Shir Tal, Galia Spectre, Ran Kornowski, Leor Perl
44 [GO] 2020―Mai―11 Treating Leukemia in the Time of COVID-19 Shilpa Paul, Caitlin R. Rausch, Nitin Jain, Tapan Kadia, Farhad Ravandi, Courtney D. DiNardo, et al. (+12)
45 [GO] 2020―Mai―06 Perspective: SARS-CoV-2, COVID-19 and Haematologists Robert Peter Gale
46 [GO] 2020―Apr―17 Multiple Myeloma in the Time of COVID-19 Abdullah S. Al Saleh, Taimur Sher, Morie A. Gertz
 [1] 

46 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.013 sec